Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017, Newcastle University
Credit: Susan Buck Ms/Public Domain

Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Over the past 10 years, there has been a large increase in the prescription of medications such as opioids and some antidepressants for .

Experts at Newcastle University, UK, have today published a study in the academic journal, PLOS ONE, which shows the serious impact of these medications and highlights the need to reduce their use.

Findings show that medications commonly used to treat pain, like gabapentinoids such as gabapentin, pregabilin and opiates, doubled the risk of obesity and were associated with poor sleep.

Study's findings

Scientists assessed the cardio-metabolic health - the inter-relationship between metabolic and cardiovascular disease - in more than 133,000 participants from the UK Biobank.

Body Mass Index, waist circumference and blood pressure were compared between those taking painkillers for chronic, non-cancer pain and cardio-metabolic drugs, compared to those prescribed cardio-metabolic treatment only.

Conditions that can require the use of this treatment include migraine, diabetic neuropathy and chronic lower back pain.

In 2016, 24 million opiates prescriptions were issued in the UK, exactly double the amount of 2006. Two years ago, 11,000 patients were admitted to hospital due to an opiate overdose.

Findings of the new study show people on opiates and cardio-metabolic drugs reported 95% rates of obesity, 82% 'very high' and 63% hypertension, as opposed to those on cardio-metabolic drugs only.

Results suggest that chronic pain medications should be prescribed for shorter periods of time to limit serious health complications.

Dr Sophie Cassidy, Research Associate at the Institute of Cellular Medicine, Newcastle University, is lead author of the study.

She said: "In the last two decades there has been a significant increase in the number of people being prescribed both opioid and non- medications to treat chronic .

"However, this is the largest study looking at the links between commonly prescribed painkillers and cardio-metabolic health.

"We already know that opiates are dependency-forming but this study also found patients taking opiates have the worst health. Obesity rates are much higher and the patients reported sleeping poorly.

"These results add further weight to calls for these medications to be prescribed for shorter periods."

Dangers of opioids

Opioids are recognised as being among the most dangerous prescription painkillers because they are addictive which can lead to them being abused. Patients can require continuous use of the drugs to feel normal and avoid symptoms of withdrawal.

In the last decade, the number prescribed has doubled and long-term use has become increasingly controversial as the causes sleep disorders, daytime sedation and accidental overdose.

Dr Kirstie Anderson, Honorary Senior Lecturer at Newcastle University and Consultant Neurologist at Newcastle Hospitals NHS Foundation Trust, co-author of the study, says the findings highlight the risks of overusing strong painkillers.

She said: "There has been recent concern about the addictive nature of opioids and a large number of side-effects, including worsening overnight breathing and therefore disturbing sleep.

"Few studies have looked at the impact of these drugs on metabolism. Our study is the largest of its kind to look at this group of drugs and show an association between obesity and .

"Further studies are need to understand how the drugs may affect metabolism over time."

Weight gain

There are a number of possible reasons why opioids can be associated with significant weight gain and obesity.

For example, they can act as a sedative which makes patients less active and they have been shown to alter taste perception with a craving for sugar and sweet foods.

Opioids are also known to worsen snoring and untreated sleep apnea, as well as causing problems with nocturnal hypertension.

Explore further: Gabapentin co-use may increase risk of fatal opioid overdose

More information: Sophie Cassidy et al, The cardio-metabolic impact of taking commonly prescribed analgesic drugs in 133,401 UK Biobank participants, PLOS ONE (2017). DOI: 10.1371/journal.pone.0187982

Related Stories

Gabapentin co-use may increase risk of fatal opioid overdose

October 3, 2017
Co-prescription of the anticonvulsant gabapentin is associated with an increased risk of opioid-related death in people who are prescribed opioid painkillers, according to a new study published in PLOS Medicine.

Plastic surgeons get tips on managing opioid addiction risk

October 2, 2017
Opioid medications prescribed for pain management after plastic surgery may contribute to the ongoing opioid epidemic, according to a special topic paper in the October issue of Plastic and Reconstructive Surgery, the official ...

Depressed patients more likely to be prescribed opioids

June 20, 2017
A new study shows that patients with low back pain who were depressed were more likely to be prescribed opioids and receive higher doses. Understanding these prescribing patterns sheds new light on the current opioid epidemic ...

What you can do to help fight the opioid epidemic

September 13, 2017
(HealthDay)—Proper disposal of prescription painkillers and use of safe alternatives to manage pain could help combat America's opioid abuse epidemic, doctors say.

Managing pain can be a puzzle after breast cancer

September 11, 2017
(HealthDay)—Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report.

When is an opioid safe to take?

June 26, 2017
(HealthDay)—Many people in pain are apprehensive about taking an opioid painkiller to ease their suffering, and rightfully so.

Recommended for you

Drug overdose epidemic has been growing exponentially for decades

September 20, 2018
Death rates from drug overdoses in the U.S. have been on an exponential growth curve that began at least 15 years before the mid-1990s surge in opioid prescribing, suggesting that overdose death rates may continue along this ...

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

Probiotic use may reduce antibiotic prescriptions, researchers say

September 14, 2018
Use of probiotics is linked to reduced need for antibiotic treatment in infants and children, according to a review of studies that probed the benefits of probiotics, say researchers in the U.S., England and the Netherlands.

Recalled blood pressure drugs not linked to increased short term cancer risk

September 12, 2018
Products containing the withdrawn blood pressure drug valsartan are not associated with a markedly increased short term risk of cancer, finds an expedited analysis published by The BMJ today.

Sugar pills relieve pain for chronic pain patients

September 12, 2018
Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to ...

A new approach for finding Alzheimer's treatments

September 11, 2018
Considering what little progress has been made finding drugs to treat Alzheimer's disease, Maikel Rheinstädter decided to come at the problem from a totally different angle—perhaps the solution lay not with the peptide ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.